To develop and validate a method of predicting whether patients will develop a heel pressure ulcer during their hospital stay. DESIGN: This retrospective case-control study used 2 separate data sets, one for an initial analysis followed by a second data set for validation analysis. SUBJECTS AND SETTING: From 2009 to 2011, medical records of discharged patients with a DRG code for heel pressure ulcers in our urban, tertiary medical center were retrospectively reviewed. Using age as the matching criterion, we then reviewed cases of patients without heel pressure ulcers. The initial analysis comprised 37 patients with hospital-acquired heel pressure ulcers and 300 without. The validation analysis included 12 patients with heel pressure ulcers and 68 without. METHOD: In order to develop this method of identifying patients with heel pressure ulcers, logistic regression modeling was used to select a set of patient characteristics and hospital conditions that, independently and in combination, predicted heel pressure ulcers. Logistic modeling produced adjusted and unadjusted odds ratios for each of the signifi cant predictor variables. The validation analysis was employed to test the predictive accuracy of the fi nal model. RESULTS: Initial analysis revealed 4 signifi cant and independent predictors for heel pressure ulcer formation during hospitalization: diabetes mellitus, vascular disease, immobility, and an admission Braden Scale score of 18 or less. These fi ndings were also supported in the validation analysis. CONCLUSION: Beyond a risk assessment scale, staff should consider other factors that can predispose a patient to heel pressure ulcer development during their hospital stay, such as comorbid conditions (diabetes mellitus and vascular disease) and immobility. KEY WORDS: heel pressure ulcers , hospitalized patient , pressure ulcer risk .
■ Introduction
Heel pressure ulcers (HPUs) are now the second most common location for pressure ulcer (PU) in adults. When we began the research for our study in 2010, we found that the National Pressure Ulcer Advisory Panel reported an average PU incidence in hospitals of 7%, of which 30% were heel ulcers. [1] [2] [3] Additionally, of the 30% who developed HPUs, 37% developed bilateral heel ulcers. 4 Lyder and colleagues 5 stated that studies suggest that the hospital-acquired PU incidence rate is 4.5% and the prevalence of PU on admission is 5.8%. Additionally, for those patients who have an ulcer on hospital admission, 16 .7% developed a new PU in a different location.
The heel is more vulnerable than other areas of the body due in part to vascular disease and tissue thinning as we age. The heel's vascular construction is located at the end of the arterial plexus from the posterior tibial and peroneal arteries. The heel contains relatively avascular fat, rendering it vulnerable to ischemia. The arteries that supply the area receive the brunt of the body weight being pressed upon the heel, and they must continue to deliver blood despite frequent and prolonged exposure to friction and shear forces. 6 The heel is exposed to high interface pressures over its surface when the person assumes a recumbent position. 7 Compounded by other factors such as aging and disease, the heel pad is less likely to absorb shock. 8 When disease processes such as diabetes mellitus), vascular disease, and neuropathies compromise vascular function in this area, the risk of pressure ulceration rises. 9 , 10 Multiple factors are postulated to contribute to HPU formation, including diabetes mellitus, vascular disease, neuropathy, 1 , 6 , 9-12 multiple sclerosis, 9 debility, 6 , 13 and hydration. Additional factors include advanced age, immobility, use of vasopressors, cognitive and sensory impairment, 6 , 10 , 13 obesity, 9 edema 6 , 9 , 14 cerebral vascular injury, spinal cord injury, 9 friction, shear, pressure, 6 , 9 prolonged surgical procedure, poor nutrition, 1 , 9 and shock/resuscitation. 13 Walsh and Plonczynski 15 found that the Braden Scale along with comorbidities can be used to determine the risk status of patients developing HPUs during hospitalization. It has been shown that the use of certain factors such as the Braden Scale may be helpful as a decision point for the prevention and reduction of heel ulcer occurrences. 1 , 16 In particular, a study by Tortual and colleagues 17 demonstrated that the Braden Scale subscales of Moisture and Friction/ Shear were predictive of HPU development. They also determined that factors such as length of stay (LOS), admitted with PU, and age were associated with HPU development.
Lyder 4 and Hunt and colleagues 18 found that intensive care unit (ICU) patients may be more vulnerable to develop HPUs because they tend to be more hemodynamically unstable and often have multiple factors and conditions that affect their stay such as poor nutrition and immobility. Schoonhoven and colleagues 19 found that the heel was the more common site for surgical PUs.
Based on this review, we identifi ed 13 factors possibly associated with an increased risk for HPU development: diabetes mellitus, vascular disease, neuropathy, admission Braden Scale score of 18 or less, age 70 or more years, immobility, perfusion problems, morbid obesity, cachexia, a surgical procedure of 3 or more hours, ICU stay more than 3 days, ventilator days more than 3 days, and activity status. The aim of this research was to develop and validate a method of predicting whether patients will develop an HPU during their hospital stay. Our ultimate goal is to create an algorithm that would assist the clinical nurse in deciding which patients would be at risk for HPU development and applying the appropriate interventions. 20 
■ Methods
This research design consisted of a retrospective case-control study; results of this evaluation were then validated using data collected from a second study group. The study setting was a tertiary, urban medical center located in New York City. The medical center includes a hospital and acute rehabilitation unit with a 705-bed capacity.
To ensure suffi cient cases for the study, we noted that our center's 2009 NDNQI hospital-acquired PUs found an incidence rate of 3.5%. The hospital has an average of approximately 33,900 discharges per year providing ample subjects for research of this nature. Cases were identifi ed based on inclusion/exclusion criteria summarized in Table 1 .
Medical records were then reviewed for presence of HPU and the 13 possible risk factors identifi ed earlier ( Box 1 ). Additional data that were collected include stage and location of any other PU, age, hospital LOS, height, weight, BMI, type of surgery, and length of procedure in minutes. Data were collected on patients discharged between 2009 and 2011.
A comparison group of patients was randomly selected who did not have an HPU diagnosis. Both groups entered the medical center during the same time period. Since this research required data extraction from medical chart review alone, an expedited review was granted by the medical center's institutional review board, NYU School of Medicine.
Of the 450 patients on whom data were collected, 113 had community-acquired HPUs and were excluded from our main analysis, resulting in 37 patients with HPUs and 
Eligibility Criteria for Main and Validation Analyses

Inclusion Criteria Exclusion Criteria
Admitted with an HPU or developed an HPU from 2009 to 2011
At least a 3-day stay ( Rationale : If a patient develops a PU during his or her hospitalization, the likelihood of doing so will be in the fi rst 2 weeks of the hospitalization. 21 In addition, some PUs take 48 to 72 h to develop. 17 , 22 , 23 ) Actively dying patients ( Rationale : PU formation at the end of life is believed to be more from skin failure rather than from disease processes, factors, and/or conditions. 24 )
Obstetric and psychiatric ( Rationale : low risk for PU formation based on their admission reasons)
Pediatric patients less than 8 years of age ( Rationale : The adult Braden Scale is used for patients 8 years and older since this age group would be treated as an adult in a cardiopulmonary resuscitation situation. These children develop PU in the same areas as adults. 25 )
300 who did not develop an HPU. Based on these numbers, an odds ratio of around 2 in favor of developing an HPU for patients with a specifi c risk factor compared to patients without the risk factor could be detected using a logistic regression model at an alpha level of .05 with 75% power. Signifi cant risk factors with odds ratios of 2 or greater could then be used to build a logistic regression model. The validation phase involved 80 patients, 12 patients with hospital-acquired HPUs and 68 patients without.
Data Analysis
Logistic regression modeling was used to select a set of patient characteristics and hospital conditions that, independently and in combination, predict the occurrence of HPUs within 3 days of hospital admission. All predictor variables were categorical, defi ning the presence or absence of a condition, except for the admission Braden Scale score, which was dichotomized at ≤ 18 versus > 18. Our motivation for dichotomizing the Braden Scale score at 18 was based on the clinical at-risk cut point identifi ed by Braden and colleagues. 26 The following scheme was used for model building. Univariate logistic regression analyses were used to select predictor variables that were signifi cantly associated with development of HPUs with a clinically meaningful odds ratio in favor of development of HPUs of 2 or greater. These predictor variables were then used in a series of stepwise procedures. Each of these stepwise procedures analyzed a distinct set of predictor variables, representing (1) disease status (diabetes mellitus, vascular disease, neuropathy); (2) physical conditions (age ≥ 70 years, immobility, perfusion issues, morbid obesity, cachexia), and (3) conditions of hospitalization (surgical procedure ≥ 3 hours, ventilator > 3 days, ICU stay > 3 days, and activity status). The admission Braden Scale score (dichotomized at ≤ 18 and > 18) was analyzed separately because the research team concluded that this structure provided a better fi t with the additional 12 factors that were exclusively dichotomous. In each stepwise analysis, variables found to be signifi cant in the univariate analyses were added to the model if their F-to-enter statistic was 0.05 and dropped from the model if their F-to-enter statistic was 0.10. Variables from each stepwise analysis that were signifi cantly and independently associated with the occurrence of HPUs were then used to develop a fi nal stepwise logistic regression model. This enabled us to select a fi nal set of predictor variables from each of the aforementioned categories, resulting in an elegant model drawing on all aspects of a patient's characteristics and conditions of hospitalization.
We used the Hosmer-Lemeshow goodness-of-fi t statistic to assess the fi t of the model. 27 A receiver operating characteristic (ROC) curve was constructed, and the AUC (area under the ROC curve) was used to estimate the diagnostic accuracy of the model. In order to estimate the probability P that a patient will develop an HPU based on certain characteristics, a formula derived from the coefficients of the fi nal logistic model is used. In practice, however, the predictors in the fi nal logistic regression model are usually used in a less formal manner to decide upon a treatment plan for a particular patient, using their odds ratios as indicators of their relative importance.
Validation Analysis
We tested our logistic model with data unrelated to the development of the model. This validation data set comprised 80 patients. For each patient in the validation sample, the probability P of developing an HPU was obtained using the regression coeffi cients from the model developed using our original sample of 337. Classifi cation tables were used for validation. These tables are commonly used to estimate overall classifi cation accuracy (% of true positives + false negatives) of a logistic model. The tables cross-classify the observed HPU status (present/absent) by the predicted probability P of developing an HPU, where P is dichotomized at a selected cut point. Tables were constructed for both the original 337 patients and the 80 patients in the validation subset and the 2 tables were compared. We chose a cut point for both tables of 0.11, which is equal to the percentage of patients with HPUs in the 337 original subjects.
When collecting data, we noted that there were considerably more community-acquired HPUs than BOX 1. hospital-acquired HPUs in our patient sample. Ancillary analyses were conducted to compare the differences between these 2 groups with respect to the variables in our fi nal model. Chi-square analyses were used for these comparisons.
The 13 Most Infl uential Factors Associated with HPU Development
■ Results
This retrospective case-control study compared 37 patients admitted to the hospital and who developed HPUs and 300 hospital patients who did not develop an HPU. Table 2 displays patient characteristics by HPU status for the main analysis. The groups differed with respect to Braden Scale scores, diabetes, vascular disease, neuropathy, perfusion issues, ICU LOS, and LOS in days; they did not differ with respect to age, morbid obesity, and cachexia. Table 3 summarizes the fi nal stepwise regression model. Statistically signifi cant and independent predictors of HPUs are shown with their regression coeffi cients with standard errors, and their adjusted odds ratios with 95% confi dence intervals. Each variable has an adjusted odds ratio of 2 or more and each variable has a P value ≤ .02 The variables that created the fi nal model were diabetes mellitus, vascular disease, immobility, and an admission Braden Scale score of 18 or less. The Hosmer-Lemeshow statistic, measuring the fi t of the model, was 1.52 ( P = .82), indicating adequate fi t. Figure 1 displays the ROC curve used to assess the overall utility of the fi nal regression model. The ROC curve plots sensitivity against (1 − specifi city) for each possible value of P (the probability of developing an HPU) obtained using our fi nal logistic regression model. The area under the curve (0.89) indicates excellent overall accuracy. Table 4 shows the sensitivity and 1 − specifi city for each value of P , as it is displayed in the ROC curve. This curve assesses the overall accuracy of the prediction of the occurrence of HPUs based on the logistic regression model. The area under the curve, 0.89, indicates good to excellent overall accuracy.
Validation Analysis
Our original sample of 337 subjects was used to derive our logistic regression model. For the validation analysis, 80 subjects were selected in the same manner as the original 337 subjects, so that there was no bias introduced by different selection methods. For this analysis, each of the 337 original subjects and each of the 80 validation subjects were classifi ed using the regression coeffi cients derived from our fi nal regression model based on the 337 original subjects.
The 2 classifi cation tables created using the original sample and the validation sample can be found in Table 5 . The cut point chosen for this table was 0.11, which is equal to the percentage of patients with HPUs in the 337 original subjects. Note that at this cut point, the overall diagnostic accuracy is high and close for the 2 samples; it is 76% for the sample of 337 and 72.5% for the sample of 80. Sensitivity is high for both the initial analysis (91.9%) and the validation analysis (83.3%). Based on these analyses, we are most concerned with recognizing as many patients as possible who have a good chance of developing HPUs, and are less concerned with including patients who will not develop HPUs in our at-risk group. In addition with either patient sample, we have a specifi city of more than 70%. 
Characteristics of Patients With HPUs and Those Without HPUs-Main Analysis
Characteristic
All Subjects (n = 337) Cases (n = 37) Controls (n = 300)
Comparison of Case and Control Groups
Age in years (mean ± SD) 73 ± 20 75 ± 19 73 ± 20 t 335 = 0.02, P = .47
Braden Scale score (mean ± SD) 18 ± 4 15 ± 3 20 ± 3 t 335 = 9.88, P < . J WOCN ■ May/June 2015
Additional Analyses
In our comparison of patients with community-acquired HPUs (n = 113) to patients with hospital-acquired HPUs (n = 37), we found that there were no signifi cant differences between groups with respect to the predictors used in our fi nal model: (diabetes mellitus: χ 2 = 0.14, P = .71; vascular disease: χ 2 = 0.07, P = .80; immobility: χ 2 = 1.81, P = .18, and Braden Scale score ≤ 18: χ 2 = 1.98, P = .16).
■ Discussion
Study fi ndings enabled us to identify certain risk factors for hospitalized patients that may lead to HPUs. Diabetes mellitus, vascular disease, immobility, and Braden Scale score of 18 or less were signifi cant predictors for HPU development during a hospital stay. In addition, we found no statistically signifi cant differences between patients who developed a hospital-acquired HPU and communityacquired HPUs with respect to these same characteristics. Abbreviation: HPU, heel pressure ulcer.
FIGURE 1.
The ROC curve showing the sensitivity and 1 − specifi city of the predicted probability of an HPU based on all combinations of the 4 binary predictive variables for the main analysis (N = 337). The area under the curve (AUC) = 0.89. This ROC curve was produced using a set of classifi cation tables based on the original sample of 337 patients. The ROC curve plots sensitivity against (1 − specifi city) for each possible value of P (the probability of developing an HPU) obtained using our fi nal logistic regression model. AUC indicates area under the ROC curve; HPU, heel pressure ulcer; ROC, receiver operating characteristic. Findings from our study are generally similar to those of other researchers. Similar to our fi ndings, Meyers 28 found that Braden Scale scores were statistically signifi cantly higher in patients with normal heels as defi ned by Goniometer measurements than in patients with abnormal heels. She concluded that this fi nding supports the use of the Braden Scale as a means to identify patients at risk for developing HPUs. McInerney 29 found that the Braden Scale score was a factor in HPU development when she noted that greater than half of HAPUs were HPUs. Based on the patient data, a specifi c heel-off-loading boot was routinely placed on all end-stage renal disease, patients, patients on ventilators, and subsequently all patients with a Braden Scale risk scale score of 13.
Using a biomechanical theory and computer modeling, Gefen 30 sought to identify HPU risk factors. He found that both diabetes mellitus and edema infl uence heel tissue responses to loading and increase the likelihood of developing an HPU. The model also demonstrated that atypical foot anatomies such as from a Charcot foot in neuropathic patients increase the likelihood of HPU occurrence. Our analysis also revealed a link between HPU development and diabetes mellitus. Edema was not specifi cally studied as a unique HPU predictor variable because it was subsumed under the category Perfusion. Nevertheless, this association warrants additional study.
Others found that aging, moisture, and deeper skin wrinkles infl uence internal soft tissue pressures over the heel. [31] [32] [33] However, Lyder and colleagues' 5 fi ndings differ from those of Gefen's 30 group. Lyder and colleagues 5 found that obesity was signifi cantly associated with HAPUs. Lyder and colleagues 5 postulated that their fi nding may be attributable to chronic impairment of perfusion in the patient who is obese resulting in chronic skin and wound issues. The heels of an obese patient may have deeper skin wrinkles, but perhaps the heels of an obese patient may not be any more susceptible than those of a patient with other comorbidities and hospital conditions.
Limitations
This research is associated with limitations. Data were collected via retrospective chart review. Analysis using a prospective cohort study design is recommended.
■ Conclusion
We identifi ed 4 predictors of HPU development: diabetes mellitus, vascular disease, immobility, and a Braden Scale score of 18 or less. We envision our work as a pathway to future research on the predictive risk factors identifi ed in this study. Our ultimate goal is to target high-risk populations so that prevention measures can be applied effectively and judiciously.
